Grifols GRFS
NASDAQ GRFS
$8.00 +0.01 (+0.13%)
At close: Aug 21, 2026 · 4:00 PM EDT

Grifols (GRFS) Deferred Taxes (2010 - 2011)

Grifols' (GRFS) quarterly Deferred Taxes came in at -$18.2 million in Q4 2011, down 186.23% YoY from $21.1 million in Q4 2010, and down 186.23% on a QoQ basis from $21.1 million in Q4 2010.

Grifols (GRFS) Deferred Taxes (2010 - 2011) Analysis & Trends

Grifols (GRFS) has 2 years of Deferred Taxes data on file, last reported at -$18.2 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn -479.00 Mn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn -195.00 Mn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn -
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn -
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn -587.00 Mn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn -1.32 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn -
10 Grifols 5.45 Bn 4.45 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2011 -18.21 Mn
Dec 31, 2010 21.11 Mn